Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

BACKGROUND AND AIMS: The aim of the study was to evaluate the risk of hepatocellular carcinoma (HCC) development after treatment with direct-acting antivirals (DAAs) and to compare HCC occurrence in these patients with that among patients treated with interferon (IFN)-based therapies. METHODS: We an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Liver Cancer
Egile Nagusiak: Finkelmeier, Fabian, Dultz, Georg, Peiffer, Kai-Henrik, Kronenberger, Bernd, Krauss, Franziska, Zeuzem, Stefan, Sarrazin, Christoph, Vermehren, Johannes, Waidmann, Oliver
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2018
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5985411/
https://ncbi.nlm.nih.gov/pubmed/29888208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486812
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak